-

Afya Announces Changes to Its Board of Directors

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that Mrs. Maria Tereza Azevedo notified the Company of her intent to resign as a member of the Board of Directors of the Company, effective as of December 31, 2025. Afya thanks Maria Tereza for her dedication and meaningful contributions to the Board and wishes her continued success in her future endeavors.

Afya’s Board of Directors is composed of two co-chairmen - one representing Bertelsmann SE&Co. KGaA, and one representing the Esteves family -, one more member of the Esteves family, two more members of Bertelsmann SE&Co. KGaA, and four independent members, resulting in a diversity of skills and experience to enhance Afya’s decision-making:

BOARD OF DIRECTORS
Name Office
Nicolau Carvalho Esteves Co-Chairman of the Board
Kay Krafft Co-Chairman of the Board
Benedikt Dalkmann Director
Christina Krebs Director
Renato Tavares Esteves Director
João Paulo Seibel de Faria Independent Director
Vanessa Claro Lopes Independent Director
Miguel Filisbino Pereira de Paula Independent Director
Marcelo Ken Suhara Independent Director

About Afya Limited (Nasdaq: AFYA, B3: A2FY34)

Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering medical practice solutions to help doctors enhance their healthcare services through their whole career.

Contacts

Investor Relations Contact:
Afya Limited
ir@afya.com.br

Afya Limited

NASDAQ:AFYA

Release Versions

Contacts

Investor Relations Contact:
Afya Limited
ir@afya.com.br

More News From Afya Limited

Afya Limited Announces Third Quarter and Nine Months 2025 Financial Results

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and nine-month period, which ended September 30, 2025 (third quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2025 High...

Afya Limited Announces Medical Seats Increase in AFYA Faculdade de Ciências Médicas Bragança

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the increase of 100 medical seats of ITPAC Porto Nacional – Instituto Tocantinense Presidente Antonio Carlos Porto S.A. (AFYA Faculdade de Ciências Médicas Bragança), in t...

Repurchase of the Series A Perpetual Convertible Preferred Shares and Repayment of Afya Participações S.A. Debentures

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that it has entered into a Share Repurchase Agreement with SBLA Holdco LLC, an affiliate of Softbank, to repurchase all 150,000 Series A Perpetual Convertible Preferred Shares of a nominal or par value of US$0.00005 each in the capital of the Company (the "Series A Preferred Shares") for...
Back to Newsroom